Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Safety and efficacy of switching to bictegravir-lenacapavir versus continuing bictegravir-emtricitabine-tenofovir alafenamide in virologically suppressed people with HIV-1 (ARTISTRY-2): a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
Journal: The lancet. HIV
Published: March 17, 2026
Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV.
Journal: AIDS (London, England)
Published: April 07, 2025
Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 29, 2024
Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 17, 2024
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Journal: The lancet. Gastroenterology & hepatology
Published: June 28, 2023
Diagnosis and Management of Genetic Iron Overload Disorders.
Journal: Journal of general internal medicine
Published: November 09, 2017
Showing 1-7 of 7
Last Updated: 09/26/2026